课题基金 / 基金详情

Zelleintritt und intrazelluläre Prozessierung von rAAV targeting Vektoren und ihrer Genome im lympho-hämatopoetischen System

Zelleintritt und intrazelluläre Prozessierung von rAAV targeting Vektoren und ihrer Genome im lympho-hämatopoetischen System
rAAV靶向载体及其基因组在淋巴造血系统中的细胞进入和细胞内加工
批准号:
22812158
负责人:
Professorin Dr. Hildegard Büning
金额:
$0.0万
依托单位国家:
德国
项目类别:
Priority Programmes
财政年份:
2006
资助国家:
德国
项目状态:
已结题
起止时间:
2005-12-31 至 2012-12-31

项目摘要

项目成果

Professorin Dr. Hildegard Büning的其他基金

相似基金

相关文献

中文摘要
翻译
通过病毒衣壳(AAV靶向载体)的遗传操作来修饰腺相关病毒(AAV)的嗜性的可能性已经创造了在全身应用后将该病毒用于细胞或组织特异性基因转移的可能性。该技术产生对靶细胞具有改善的转导效率的载体。同时,需要较低剂量的载体(避免非靶组织对载体的非特异性摄取)。然而,对这种AAV靶向载体的细胞进入、内体加工和核转运知之甚少。由于插入的配体介导靶向载体的细胞进入,因此靶向载体的细胞进入途径和细胞内命运可能不同于野生型AAV(wtAAV)。此外,靶向载体可用于进行基因转移到wtAAV非允许细胞中。利用不同的进入途径或细胞内途径可能引发不可预见的副作用,如原癌基因附近的基因组整合或控制细胞生长或程序性细胞死亡的细胞内信号传导途径的失调。出于这个原因,拟议项目的目的是详细分析淋巴造血系统细胞中AAV靶向载体的细胞进入、细胞内运输和核进入。此外,将分析病毒整合位点在细胞基因组中的发生和位置。最后,将进行微阵列分析、细胞存活和细胞周期分析以测量(重靶向)AAV感染对细胞稳态的影响。
英文摘要
The possibility to modify the tropism of adeno-associated virus (AAV) by genetic manipulation of the viral capsid (AAV targeting vector) has created the possibility for using this virus for a cell or tissue specific gene transfer after systemic application. This technology produces vectors with improved transduction efficiency on target cell. At the same time, lower does of vector are required (circumvention of unspecific uptake of vectors in non-target tissue). However, little is known about cell entry, endosomal processing and nuclear transport of such AAV targeting vectors. Since the inserted ligand mediates the cell entry of the targeting vectors, it is likely that the cell entry pathway and the intracellular fate of targeting vectors differ from wild-type AAV (wtAAV). In addition, targeting vectors may be used to perform gene transfer into wtAAV non-permissive cells. Utilization of different entry routes or intracellular pathways may trigger unforeseen side effects like genomic integration in proximity of proto-oncogenes or dysregulation of intracellular signalling pathways controlling cell growth or programmed cell death. For this reason, the aim of the proposed project is a detailed analysis of cell entry, intracellular trafficking and nuclear entry of AAV targeting vectors in cells of the lympho-hematopoietic system. Furthermore, the occurrence and location of viral integration sites into the cellular genome will be analysed. Finally, microarray analyses, cell survival and cell cycle analyses will be performed to measure the influence of a (retargeted) AAV infection on cell homeostasis.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
Autophagic and Epigenetic Control of Liver-Directed Gene Therapy with Adeno-Associated Viral Vectors
  • 批准号:
    431535912
  • 项目类别:
    Research Grants
  • 资助金额:
    $0.0万
  • 财政年份:
    2020
  • 负责人:
    Professorin Dr. Hildegard Büning
  • 依托单位:
Development of in vivo secreted antiviral entry inhibitory peptides for the treatment of HIV-infection
  • 批准号:
    131542860
  • 项目类别:
    Research Grants
  • 资助金额:
    $0.0万
  • 财政年份:
    2009
  • 负责人:
    Professorin Dr. Hildegard Büning
  • 依托单位:
AAV-mediated intra-tumoral immunotherapy for the treatment of immunologically “cold” tumors
海外基金